Rilonacept and canakinumab

被引：53
作者：
Dubois, Eline A.
Rissmann, Robert
Cohen, Adam F.
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 71卷 / 05期
关键词：
D O I：
10.1111/j.1365-2125.2011.03958.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：639 / 641
页数：3
相关论文
共 4 条
  • [1] Actual status of antiinterleukin-1 therapies in rheumatic diseases
    Geyer, Matthias
    Mueller-Ladner, Ulf
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (03) : 246 - 251
  • [2] Hoffman HM, 2008, NAT REV DRUG DISCOV, V7, P385, DOI 10.1038/nrd2579
  • [3] Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
    Lachmann, Helen J.
    Kone-Paut, Isabelle
    Kuemmerle-Deschner, Jasmin B.
    Leslie, Kieron S.
    Hachulla, Eric
    Quartier, Pierre
    Gitton, Xavier
    Widmer, Albert
    Patel, Neha
    Hawkins, Philip N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) : 2416 - 2425
  • [4] Rilonacept-CAPS and Beyond A Scientific Journey
    Stahl, Neil
    Radin, Allen
    Mellis, Scott
    [J]. CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS, 2009, 1182 : 124 - 134
1